FDA DrugClass IIINotable
FDA Recall: Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, I
Description
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Hazard
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Remedy
164 cartons
Related Recalls
2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.
2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.
2026-04-22 · FDA_DRUG
FDA Recall: Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.
Cipla USA, Inc.
2026-04-15 · FDA_DRUG
FDA Recall: Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single
Cipla USA, Inc.